GENRX CLOMIPHENE clomifene citrate 50mg tablet blister

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

clomifene citrate, Quantity: 50 mg

Доступно од:

Arrotex Pharmaceuticals Pty Ltd

Фармацеутски облик:

Tablet, uncoated

Састав:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; lactose monohydrate; maize starch; povidone

Пут администрације:

Oral

Јединице у пакету:

5 tablets

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

INDICATIONS: Clomiphene citrate is indicated in the treatment of ovulatory failure in patients desiring pregnancy, whose partners have adequate sperm and who have potentially functional hypothalamic-hypophyseal ovarian systems and adequate endogenous oestrogens. Impediments to this goal must be excluded or adequately treated before beginning therapy. Administration of Clomiphene is indicated only in patients with demonstrated ovulatory dysfunction and in whom the following condition apply: 1. Demonstration of normal liver function 2. Physiological indications of normal or near normal endogenous oestrogen levels should be present (as estimated from vaginal smears, endometrial biopsy, assay of urinary or serum oestrogen or from bleeding in response to progesterone). Reduced oestrogen levels, while less favourable, do not prevent successful therapy. 3. Clomiphene citrate is not effective in patients with primary pituitary or ovarian failure. It cannot substitute for appropriate therapy of other disturbances leading to ovulatory dysfunction, e.g. diseases of the thyroid or adrenals. 4. Patients with abnormal uterine bleeding should be thoroughly evaluated prior to initiating Clomiphene therapy. It is most important that neoplastic lesions are detected.

Резиме производа:

Visual Identification: White round biconvex tablets with a score on one side.; Container Type: Blister Pack; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius

Статус ауторизације:

Licence status A

Датум одобрења:

2001-07-26